Latest news and articles about Lyme disease from NEX English
This year's tick season has started earlier than usual, raising alarm among experts about potential disease outbreaks. Reports indicate that increased tick activity could lead to the spread of tick-borne illnesses.
Pfizer, in collaboration with French partner Valneva, announced its intention to seek regulatory approval for a Lyme disease vaccine after successful advanced clinical trials. This initiative comes amid growing interest in new methods to combat this globally significant health threat.